Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Sanofi (SNYNF) Gets a Hold from Kepler Capital

Tipranks - Tipranks - Wed Apr 1, 8:50PM CDT

In a report released on March 30, Nicolas Pauillac from Kepler Capital maintained a Hold rating on Sanofi, with a price target of €85.00. The company’s shares closed yesterday at €81.90.

End of Quarter Sale - 50% Off TipRanks

According to TipRanks, Pauillac is a 5-star analyst with an average return of 15.2% and a 51.50% success rate. Pauillac covers the Healthcare sector, focusing on stocks such as Eckert & Ziegler Strahlen und Medizintechnik, Sanofi, and Formycon AG.

In addition to Kepler Capital , Sanofi also received a Hold from UBS’s Matthew Weston in a report issued on March 30. However, on March 26, TipRanks – Google reiterated a Buy rating on Sanofi (Other OTC: SNYNF).

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of €103.64 and a one-year low of €74.85. Currently, Sanofi has an average volume of 2.42M.

Read More on SNYNF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).